Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Epilepsy & Behavior : E&B
|
May 27, 2022
Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis
Robb Wesselingh, James Broadley, Katherine Buzzard, et al.
The Australian and New Zealand Journal of Psychiatry
|
October 1, 2020
Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
Christos Pantelis, Mahesh Jayaram, Anthony J Hannan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2011
Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses
Alice E Denton, Robb Wesselingh, Stephanie Gras, et al.
Journal of Neurology
|
June 25, 2024
Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms
Sarah P Griffith, Robb Wesselingh, Nabil Seery, et al.
BMJ Neurology Open
|
May 13, 2024
Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic
Louise Rath, Wei Zhen Yeh, Angie Roldan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 15, 2024
Language impairments in seropositive and seronegative autoimmune encephalitis
Sarah P Griffith, Robb Wesselingh, Fiore D'Aprano, et al.
Epilepsia
|
March 18, 2024
Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)
Daniel J Costello, Elizabeth Matthews, Sidra Aurangzeb, et al.
International Journal of MS Care
|
June 28, 2021
Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders
Louise Rath, Maria Pia Campagna, Jim Stankovich, et al.
BMJ Neurology Open
|
February 14, 2025
Monitoring the neurological complications of chimeric antigen receptor (CAR) T-cell therapy in patients with sensory and physical impairments and non-native-speaking backgrounds using modified immune effector cell-associated encephalopathy (ICE) scores: a case series
Christina Kazzi, Ty Simpson, Cassandra Abbott, et al.
Journal of Neuroimmunology
|
August 14, 2025
Neurotoxicity associated with chimeric antigen receptor T-cell therapy
Miriam Wronski, Robb Wesselingh, Christina Kazzi, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Epilepsy & Behavior : E&B
|
May 27, 2022
Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis
Robb Wesselingh, James Broadley, Katherine Buzzard, et al.
The Australian and New Zealand Journal of Psychiatry
|
October 1, 2020
Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
Christos Pantelis, Mahesh Jayaram, Anthony J Hannan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2011
Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses
Alice E Denton, Robb Wesselingh, Stephanie Gras, et al.
Journal of Neurology
|
June 25, 2024
Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms
Sarah P Griffith, Robb Wesselingh, Nabil Seery, et al.
BMJ Neurology Open
|
May 13, 2024
Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic
Louise Rath, Wei Zhen Yeh, Angie Roldan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 15, 2024
Language impairments in seropositive and seronegative autoimmune encephalitis
Sarah P Griffith, Robb Wesselingh, Fiore D'Aprano, et al.
Epilepsia
|
March 18, 2024
Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)
Daniel J Costello, Elizabeth Matthews, Sidra Aurangzeb, et al.
International Journal of MS Care
|
June 28, 2021
Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders
Louise Rath, Maria Pia Campagna, Jim Stankovich, et al.
BMJ Neurology Open
|
February 14, 2025
Monitoring the neurological complications of chimeric antigen receptor (CAR) T-cell therapy in patients with sensory and physical impairments and non-native-speaking backgrounds using modified immune effector cell-associated encephalopathy (ICE) scores: a case series
Christina Kazzi, Ty Simpson, Cassandra Abbott, et al.
Journal of Neuroimmunology
|
August 14, 2025
Neurotoxicity associated with chimeric antigen receptor T-cell therapy
Miriam Wronski, Robb Wesselingh, Christina Kazzi, et al.
Page
of 6